Accompanying transcranial magnetotherapy in combination treatment of high-grade glial brain tumors

Introduction. Low survival and poor quality of life in patients with high-grade brain gliomas (HGG) dictate the need to develop and promote new approaches, including accompanying transcranial magnetic therapy (TMT) with pulse-type magnetic field (PT MF) and ultra-low-frequency magnetic fields (ULF MF), characterized by their non-invasiveness and safety in applied procedures. The key point of these original wave technologies is the construction of algorithms of the actions based on the principles of activation therapy, which was developed as a result of the discovery “Pattern of development of qualitatively differing general nonspecific adaptational reactions of the organism” (Scientific Discovery Registration Certificate No. 158 issued by the Committee on Inventions and Discoveries at the Council of Ministers of the USSR, 1975).